XBiotech has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities in its Phase II trial.

The investigational therapy works to impede the expression of genes that cause the body to store fat as a potential treatment for obesity.

Marengo's Phase II trial is assessing T cell activator invikafusp alfa in the treatment of advanced PD-1 resistant solid tumours.

AI continued to be shown as an invaluable tool with the potential to accelerate clinical trials and improve patient care.

Modified Rodnan Skin Score is the primary endpoint of the TibuSURE trial. Credit: Cesare Andrea Ferrari/Shutterstock. Zura Bio has initiated the double-blind Phase II TibuSURE trial to assess the ...

Both trials recruited patients with psoriatic arthritis who had not previously received biologic disease-modifying antirheumatic drugs.

There have been several impactful clinical trial read outs in 2024. Image credit: Shutterstock / Rajitha Tennakoon From gene therapies to psychedelics and cancer vaccines to HIV pre-exposure ...

Trevi has announced that its Phase IIb trial of Haduvio in treating IPF subjects with chronic cough will continue without sample size change.

The Phase III trial is set to use growth outcomes as its primary endpoint in the 52-week trial of JR-142, a long-acting growth hormone.

Adicet Bio has dosed the first subject in a multicentre Phase I trial of ADI-270, a gamma delta CAR T-cell therapy for treating ccRCC.